About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Gene Testing in Patients With Colon Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00003571

Gene Testing in Patients With Colon Cancer

RATIONALE: Analyzing the structure of genes found in a person's cancer cells may help doctors improve methods of treating patients with colon cancer. PURPOSE: Clinical trial to study the genes of pat...

Lead sponsor: Alliance for Clinical Trials in Oncology•44 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

National Cancer Institute (NCI)

OBJECTIVES: * Determine the relationship between disease free survival, overall survival, and tumor replication error status for patients who have received adjuvant chemotherapy for colon cancer on CALGB protocol 8896. * Determine the prognostic and predictive values for response to this therapy in these patients.

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•DISEASE CHARACTERISTICS:
•Patients who received chemotherapy for colon cancer as part of CALGB protocol 8896
•Underwent an initial resection for adenocarcinoma of the colon and were determined to have a high risk of tumor recurrence based upon nodal disease or local extension of tumor with obstruction or perforation due to tumor
•Surgical specimen blocks available, including tumor tissue and normal tissue

Related studies

RECRUITINGPhase 2

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

NCT07446322 · Ras-mutated Metastatic Colorectal Cancer, mCRC, and more

RECRUITINGPhase 1

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

NCT02600949 · Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, and more

RECRUITINGPhase 1/2

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264 · Cancer, Colorectal Cancer, and more

The Impact of Image-Assisted Colonoscope on Patient Experience, Physician Workload, and Examination Quality

NCT07541924 · Colorectal Cancer Screening, Colonic Polyps/Colonoscopy/Colorectal Neoplasms, and more

Assessing the Efficacy and Safety of ctDNA-driven Selection for Anti-EGFR Retreatment in a Real World Metastatic Colorectal Cancer Patients Cohort (the REalCHALLENGE Study)

NCT07536113 · Metastatic Colorectal Cancer (CRC)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 6, 2016Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment300

Start dateAug 1998

Last updatedJul 6, 2016

Condition

Colorectal Cancer

Locations shown

Veterans Affairs Medical Center - Birmingham

Birmingham, Alabama

University of California San Diego Cancer Center

La Jolla, California

Veterans Affairs Medical Center - San Francisco

San Francisco, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 6, 2016Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions